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Abstract 
The cogrinding technique is one of most effective methods for improving the dissolution of 
poorly water soluble drugs and it is superior to other approaches from an economical as well 
as an environmental stand point, as the technique does not require any toxic organic solvents. 
Present work explores the role of D-glucosamine HCl (GL) as a potential excipient to 
improve dissolution of a low melting point drug, ibuprofen (Ibu), using physical mixtures and 
coground formulations. The dissolution of the poorly soluble drug has been improved by 
changing the ratio of Ibu:GL and also grinding time. The results also showed that although 
GL can enhance the solubility of Ibu, it also reduces pH around the Ibu particles which led to 
poor dissolution performance when the concentration of GL is high. The effect of GL on the 
solubility of Ibu could be misleading if the pH of the final solution was not measured. 
Grinding reduced the particle size of GL significantly but in case of Ibu it was less effective. 
Solid state analysis (XRPD, DSC and FT-IR) showed that ibuprofen is stable under grinding 
conditions, but the presence of high concentration of GL in samples subjected to high 
grinding times caused changes in FT-IR spectrum of Ibu which could be due to 
intermolecular hydrogen bond or esterification between the carboxylic acid group in the 
ibuprofen and hydroxyl group in the GL.  
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Introduction 
It is well established that the active ingredient in a solid dosage form must undergo 
dissolution before it is available for absorption from the gastrointestinal tract. Many potential 
drug candidates are characterized by a low oral bioavailability due to their low solubility or 
dissolution rate. This is the reasoning behind the enhancement of the dissolution or solubility 
of poorly water soluble drugs particularly Class II drugs. Researchers have applied several 
techniques to improve the drug dissolution, namely micronization,1 solid dispersion,2 solvent 
deposition,3 ordered mixtures,4 roll-mixing 5 and complexation.6 The size reduction method 
has also been extensively utilised7-8 because the increase in surface area can enhance the 
dissolution and consequently the bioavailability of pharmaceutical materials. Size reduction 
of pharmaceutical materials is often performed by the dry milling process, but the size 
reduction by dry milling is limited at around 3 µm due to aggregation between particles. 
Grinding is generally used for reducing particle size since the dissolution is strongly affected 
by particle size. It has been reported that a strong force (such as grinding) may increase the 
surface free energy and cause distortion of the crystal lattice as well as reducing particle size.9 
It has been reported that the size reductions in nanometer range can be carried out by other 
techniques such as salt-assisted milling.10 Recent research has explored particle size reduction 
to the submicron region by cogrinding with additives.11-14 Cogrinding is economically and 
environmentally desirable as, unlike other techniques, it does not require toxic solvents15 and 
sophisticated equipment.16 Although ibuprofen (Ibu) particle size is small enough to dissolve 
well, it is poorly soluble in an aqueous solution. It belongs to class II of the 
biopharmaceutical classification system (BCS) and is characterized by a high per-oral dose, 
low aqueous solubility and high membrane permeability. Therefore, the bioavailability of 
ibuprofen is limited by the poor dissolution.  
Glucosamine (GL) is a naturally occurring, highly water soluble, non-toxic compound 
derived from the exoskeletons of arthropods. When it is given orally, it has been shown to 
decrease pain and improve mobility in osteoarthritic joints of humans.17-18 This has led to its 
popular use as a nutritional supplement in both humans and dogs. This monosaccharide is one 
of a family of amino sugars and is a weak base. Due to the instability of glucosamine, its salts 
(either hydrochloride or sulphate) are used in therapy19 but glucosamine HCl is more stable 
than glucosamine sulphate.20 Our previous results showed the ability of glucosamine as a 
hydrophilic carrier to enhance the dissolution of CBZ in solid dispersion formulations 21 and 
ground formulations containing piroxicam.22 Ibuprofen has a low melting point (around 76 
oC) compared to carbamazepine (192 oC) and piroxicam (around 200 oC) and it is not clear 
that glucosamine could be a potential excipient to improve the dissolution of low melting 
points drugs such as ibuprofen from coground formulations as under grinding conditions 
ibuprofen might melt. In other words, the melting point of ibuprofen is fairly low compared 
to piroxicam and carbamazepine and during grinding the temperature can go up closer to the 
melting point of ibuprofen.  Therefore, this work explores the use of D-glucosamine HCl as a 
potential excipient to improve the dissolution of drugs with low melting points such as 
ibuprofen in coground formulations. Meanwhile, the effect of the order of grinding on 
dissolution of ibuprofen was also investigated. The physicochemical characteristics and solid 
state of the prepared coground systems, morphology of particles and their solid state were 
also studied to investigate any interaction between drug and glucosamine HCl. 
 
 
 
 
 
Materials and methods 
Materials 
Ibuprofen (Ibu) was purchased from Spectrum (USA). D-(+)-glucosamine hydrochloride 
(Sigma, USA) was used as a hydrophilic carrier. All materials were of analytical grade and 
used as obtained. 
Preparation of coground mixtures of drug-carrier 
Coground samples of different ratios of drug to carrier (4:1, 1:4, and 1:10) were prepared 
using ball mill (Fritsch, Germany). The total amount of drug: carrier was kept constant for all 
formulations (20 g). The volume of the ball mill chamber was 250 ml and eight steel balls 
were used with diameter of 20 mm occupying one third of volume of the chamber. The 
vibration rate was set to 400 rpm. The samples were subjected to different grinding times (1, 
10 and 20 minutes). In order to investigate the effect of grinding process on dissolution 
behaviour of ibuprofen, the drug was ground separately in absence of glucosamine. Then the 
mixture of ground ibuprofen and un-ground D-glucosamine HCl were prepared by mixing 
them in a tubula blender for 10 min. Different ratios of drug: carrier (4:1, 1:4 and 1:10) were 
prepared for comparison purposes. After mixing, the powders were stored in a screw-cap 
glass vial at room temperature until used. 
An attempt was also made to further investigate the effect of ibuprofen’s particle size on 
dissolution by preparing different size fractions of ibuprofen (63-90, 90-125, 125-250 and 
>250 µm). Different source of ibuprofen with a wider particle size distribution was purchased 
from IMCD (UK) to get the different size fractions for this study. 
 
 
 
 
Preparation of ground ibuprofen 
Ibuprofen was ground on its own for different grinding times 1, 10 and 20 min. This was 
carried out to investigate the effect of grinding time on ibuprofen dissolution behaviour in the 
absence of any excipients. 
 
Preparation of physical mixtures of drug-carrier 
Physical mixtures of drug and carrier were prepared by mixing ibuprofen and D-glucosamine 
hydrochloride in a turbula blender for 10 min. The same ratios of drug: carrier (4:1, 1:4 and 
1:10) were also used in the preparation of physical blends as used in the preparation of 
coground formulations. This was to ensure a comparison could be made with the ground Ibu-
glucosamine formulations. The physical mixtures were stored in a screw-cap glass vial at 
room temperature until used. 
 
Solubility studies 
Solubility of ibuprofen was performed according to a previously published method.22 Also, 
an excess of ibuprofen was added to 10 mL of phosphate buffer pH 7.4 containing different 
concentrations of D-glucosamine hydrochloride. The capped test tubes were shaken at 37 ◦C 
for 72 h in a water bath (Clifton, UK). Subsequently, the suspensions were filtered through a 
0.45-µm membrane filter, and the filtrates were diluted with pH 7.4 phosphate buffer to get 
absorbance between 0.1 and 1.5 (a calibration curve was constructed for different 
concentrations of ibuprofen solutions at pH 7.4 with a correlation coefficient of 0.999). The 
diluted solutions were analyzed to determine the concentration of ibuprofen using a UV 
spectrophotometer (Shimadzu 160A) at 221 nm. The solubility results reported in Table 1 are 
the mean and standard deviation of at least three determinations. The preliminary results 
showed that there was no interference between ibuprofen and glucosamine at this 
wavelength. 
 
Dissolution studies 
A USP dissolution apparatus no. 1 (basket method) was used to monitor the dissolution 
profiles of ibuprofen ground powders and physical mixtures. All formulations used to fill the 
capsules contained the same amount of ibuprofen drug content (200 mg).  The dissolution 
medium was 900 mL pH 7.4 equilibrated to 37 ̊C and the baskets were rotated at 75 rpm 
according to USP XXVIII. From the dissolution flask, samples were withdrawn at selected 
time intervals (5, 10, 15, 20, 25, 30, 40, 50, 60, 75, 90, 105 and 120 min) using a peristaltic 
pump and the concentrations of ibuprofen in the samples were determined by UV 
spectrophotometer at 221 nm. A minimum of three determinations for each sample was 
carried out. For comparison purposes, dissolution testing was carried out for all the physical 
mixtures.  
Dissolution parameters 
Various dissolution parameters, namely dissolution efficiency (DE), mean dissolution time 
(MDT) and mean dissolution rate (MDR), were used to quantify the dissolution performance 
of ibuprofen formulations.  The DE of a pharmaceutical dosage form is defined as the area 
under the dissolution curve up to the time, t, expressed as the percentage of the area of the 
rectangle.23 
 
 
 
Where y is the percent of drug dissolved at time t. 
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The MDT is the most likely time for a molecule to be dissolved from a solid dosage form. 
This is calculated using the following equation:  
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Where j is the sample number, tj is the midpoint of the jth time interval (easily calculated with 
((t + t-1)/2) and Mj is the additional amount of drug dissolved between tj and t-1. 
 
The MDR can be calculated according to the following equations.  
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Where n is the number of dissolution sample times, t is the time at midpoint between t and 
t-1, easily calculated with [t + (t-1)/2]. 
 
Scanning electron microscopy 
Electron micrographs of ibuprofen ground mixtures were obtained using a scanning electron 
microscope (Leica Cambridge S360, UK) operating at 15 kV. The samples were mounted on 
a metal stub with double-sided adhesive tape and coated under vacuum with gold in an argon 
atmosphere prior to observation. Micrographs with different magnifications were taken to 
study the morphology of the ground mixtures. 
 
Fourier transform infrared (FT-IR) studies 
 FT-IR spectra (range 650-4000 cm-1) of ibuprofen ground mixtures or physical mixtures 
were recorded using ATR with an FT-IR spectrophotometer (PerkinElmer, UK).  A few 
milligrams of sample were placed on the middle of the sample stage using a micro spatula 
and force applied by twisting the top of the arm of the sample stage. The spectra were the 
result of averaging 4 scans at 1 cm-1 resolution.  
 
Differential scanning calorimetery (DSC) studies 
Samples of ground or physical mixtures of ibuprofen-glucosamine (3-6 mg) were placed in 
standard aluminium pans (40 µl) sealed with a lid. The crimped aluminum pans were heated 
from 20 to 350 ˚C at a scanning rate of 10 ˚C/min under nitrogen gas. The enthalpy, onset 
temperatures and melting points of the samples were automatically calculated using the 
software provided (Mettler-Toledo, Switzerland). 
 
Results and discussion 
Dissolution studies 
The release profiles of ibuprofen from mixtures of ibuprofen-glucosamine with different 
ratios ground for different times (1, 10 and 20 min) are shown in Figures 1a to 1c. It is clear 
from Figure 1a that the dissolution of untreated ibuprofen is not as good as coground 
samples. When ibuprofen-glucosamine mixture with the ratio of 4:1 was subjected to 
different grinding times an improvement in the dissolution was observed. Figure 1a shows 
that grinding time has an impact on the dissolution of ibuprofen from ground samples. When 
the ratio of drug:carrier was 4:1, 1 min grinding was sufficient to produce the fastest 
dissolution. For the samples containing a high glucosamine concentration (ratio of drug to 
carrier 1:4 and 1:10, Figures 1b, 1c), a reduction in dissolution was observed with most of the 
coground samples of the ibuprofen-glucosamine giving a lower dissolution than that of the 
untreated ibuprofen. This could be due to a reduction in the pH of the dissolution medium 
around ibuprofen particles at high concentration of glucosamine. Glucosamine is a weak base 
which can reduce the pH of the dissolution medium around ibuprofen particles when it 
dissolves (the pH of 1, 5, 10 and 15 %w/v of glucosamine HCl in phosphate buffer in absence 
of ibuprofen with nominal pH of 7.4 measured immediately was reduced to 6.4, 5.8, 5.3 and 
3.4 respectively). Therefore, as the solubility of ibuprofen is pH dependent,24 the dissolution 
rate of ibuprofen is expected to decline when pH reduces due to the presence of an increasing 
content of glucosamine in the samples.  
 
Figure 1a also shows that an increase in the grinding time from 1 min to 20 min caused a 
reduction in the dissolution of ibuprofen samples. This reduction with an increase in grinding 
time was still an improvement over that of the untreated ibuprofen samples. This is an 
advantage for high dose drugs such as ibuprofen and carbamazepine as generally the final 
weight of the mixtures of these drugs with carrier to produce high dissolution rate can exceed 
1 g and it is often difficult to accommodate more than 1 g powder in a capsule. The results 
presented here showed that glucosamine could be an ideal carrier to enhance the dissolution 
rate of ibuprofen at low concentration of glucosamine and low grinding times. In addition, the 
presence of glucosamine in ibuprofen would be of extra benefit as it has been proved that 
glucosamine is a useful chemical in osteoarthritis.25   Comparing all dissolution profiles in 
Figure 1 shows that the effect of grinding time is dependent on the ratio of Ibu:GL used in the 
formulation.  
 
These results indicated that there is an optimum level for glucosamine to increase the 
dissolution of ibuprofen and beyond this optimum, the drug dissolution decreases which 
could be due to a reduction in the pH of the solution as more glucosamine was used. This is 
consistent with solid dispersion data previously reported for carbamazepine,21 where the 
dissolution rate of CBZ was improved by the presence of glucosamine but there was an 
optimal concentration of the carrier to have a maximum dissolution 
 The above conclusion was supported by DE, MDT, and MDR reported in Table 1. On the 
basis of these dissolution parameters the highest DE120min (69.0%) and MDR (1.14 % min-1) 
and the lowest MDT (27.7 min) was observed for the sample with the ratio of drug to carrier 
4:1 ground for 1 min. This indicated that the cogrinding of ibuprofen with GL can 
significantly improve dissolution efficiency of ibuprofen samples. DE data showed that 
cogrinding of ibuprofen-glucosamine above 1 min at 4:1 ratio did not improve or change the 
DE remarkably (Table 1).  
 
Dissolution of ibuprofen from physical mixtures showed that the presence of glucosamine 
was unable to increase the dissolution of ibuprofen (Figure 2), even in case of 4:1 and 1:4 a 
reduction in dissolution efficiency of the samples was observed (in Table 1, grinding time 0 is 
an indication of physical mixture). An increase in DE of physical mixtures of ibuprofen-
glucosamine from 31.5% (Ibu:GL, 4:1, concentration of GL is 20%) to 46.9% (Ibu:GL, 1:10, 
concentration of GL is 91%) occurred. However, there was no significant difference (p>0.05) 
between the 1:10 ratio with untreated ibuprofen (DE was 45.4%) indicating that the presence 
of glucosamine in the physical mixtures of ibuprofen was unable to enhance the dissolution 
rate of ibuprofen significantly (Figure 2).  
 
To investigate the effect of grinding on untreated ibuprofen on its dissolution, the second 
series of experiments was designed. In this series the untreated ibuprofen was ground for 1, 
10 and 20 min in the absence of glucosamine. The dissolution profiles and dissolution 
parameters for this series of experiments are shown in Figure 3 and Table 1 respectively. 
Table 1 showed that the ground ibuprofen caused a significant reduction in the dissolution of 
the untreated ibuprofen (as from manufacturer) (ANOVA test, p< 0.05). The reduction in the 
dissolution of ibuprofen could be due to the presence of larger ibuprofen particles as a result 
of agglomeration (Table 2). The presence of very fine and large ibuprofen particles caused an 
increase in span values, indicating wider particle size dissolution.  However, enhancing the 
dissolution of poorly water soluble drugs by grinding such as griseofulvin26 and naproxen27 
has been reported. 
 
Although Table 2 shows that the coground samples demonstrated different average particle 
sizes, no relationships between particle size and dissolution was established. For example, 
high grinding time reduced the average particle size of coground samples from 20.0±1.1 
(ratio of drug:carrier 1:10, ground for 1 min) to 1.9±0.04 µm when grinding time was 
increased to 20 min (Table 2). On the basis of particle size, one would expect to see a 
significant increase in the dissolution of the ground sample for 20 min. There was however a 
slight increase in the dissolution efficiency of this sample (around 5% increase compared to 
the sample ground for 1 min) (Table 1) though this increase was not statistically significant 
(p>0.05). This suggests that a reduction in the particle size of coground samples may not be 
the solution to improving the dissolution of ibuprofen. The authors believe that due to the 
presence of high surface energy for smaller particles these particles might aggregate when 
exposed to the dissolution medium whereas this is not the case for larger particles. This could 
be a reason for coground formulations with very fine articles in some formulations showed 
slower dissolution (see Tables 1 and 2).   
 
On the basis of the above conclusion, the effect of ibuprofen’s particle size (63-90, 90-125, 
125-250 and >250 µm) on dissolution was carried out and the results were shown in (Figure 
4) (a different source of ibuprofen with a wider particle size distribution was purchased from 
IMCD (UK) to get the different size fraction for this study). The figure shows the smaller 
particles (63-90 µm) to have the slowest dissolution behaviour compared to the larger 
particles (>250 µm) which could be due to the aggregation of smaller particles as a results of 
high surface energy.  The other fractions showed slightly faster dissolution than the smallest 
and the largest size fractions. This indicates that the presence of agglomerated drug particles 
can reduce the drug dissolution. 
 
Although Figure 3 showed that the grinding of pure ibuprofen did not enhance the dissolution 
efficiency (Table 1), it was decided to explore whether pure ground ibuprofen can show 
similar behaviour in the mixture of ground ibuprofen with unground glucosamine (Figure 5 
and Table 1). The results showed that, in contrast to pure ground ibuprofen samples (Figure 
3), all samples containing ground ibuprofen (ground for 10 or 20 min) mixed with unground 
glucosamine produced the highest dissolution efficiency except the ratio of drug to carrier 
1:4. This indicates that the dissolution behaviour of ground ibuprofen in the presence of 
carrier is different to the dissolution behaviour of pure ground ibuprofen per se. The 
dissolution of ground ibuprofen alone cannot dictate the dissolution of ibuprofen in the 
mixtures with glucosamine. The authors believe that the ground ibuprofen can be easily 
dispersed and attached to the surface of the larger glucosamine particles (ordered mixture, 
Figure 6). This in turn reduces the agglomeration tendency of the fine ground ibuprofen 
particles when exposed to the dissolution medium. This shows that when untreated ibuprofen 
was ground alone for 10 or 20 min and mixed physically with the carrier, higher carrier is 
needed to produce faster drug dissolution.  
 
It is obvious from the above explanation the coground samples of ibuprofen: glucosamine 
showed conflicting effect of the micronization technique on the dissolution of ibuprofen 
samples (e.g., the effect of size of particles, concentration of carrier and micronization time). 
These contradictory results do not align with the normal effect of micronization technique on 
the dissolution of different coground mixtures. It is believed that the higher micronization 
time might cause the agglomeration of particles which has direct relationship to high surface 
energy of particle.  The increase or reduction in the dissolution of ibuprofen might be 
attributed to the increase in wettability or reduction in pH of the dissolution medium by the 
presence of glucosamine which is discussed later in the manuscript.  
 
In summary, all dissolution profiles generally showed that the fastest dissolution was 
obtained when ground ibuprofen (ground for 10 or 20 min) was mixed with unground 
glucosamine (ratio of drug:carrier 1:10). This was closely followed by cogrinding of 
ibuprofen with glucosamine for 1 min when the ratio of Ibu:GL was 4:1. This shows that 
practically it is impossible to embed 2200 mg ibuprofen-glucosamine (1:10) into a capsule 
whereas in the case of 4:1 ratio the final weight of the samples would be 240 mg. On the 
basis of this coground formulation of ibuprofen-glucosamine at the ratio of 4:1 is preferable. 
 
Different parameters, such as the ratio of glucosamine, grinding time, and the type of 
grinding (alone or cogrinding) affected the dissolution of ibuprofen. Each parameter either 
enhanced or reduced the dissolution of ibuprofen by practicing one or more of the positive or 
negative effects, respectively. The positive effects include enhancement of ibuprofen by 
exerting one or more of the following: reduction of ibuprofen particle size, dispersion of 
glucosamine between ibuprofen, adsorption of fine particles of ibuprofen on the surfaces of 
glucosamine particles, and improved ibuprofen wettability by glucosamine.  
 
Several studies have reported that an increase in the dissolution of coground samples is due to 
an enhancement in solubility of drugs in the presence of hydrophilic carrier.28 The presented 
results show that an increase in the concentration of GL up to 5% w/v increased the solubility 
of ibuprofen, but further increase in the concentration of GL caused a reduction in the 
solubility from 21.2 mg/ml to 12.3 mg/ml which could be due to a reduction in the actual pH 
of the solution at the end of the solubility testing procedure due to the use of HCl salt of 
glucosamine instead of glucosamine base (Table 3). For example the pH of the solution 
containing 1% GL after 72 h in the presence of ibuprofen in the solubility test was 6.4 
whereas in case of 15% GL it was 2.2. As the solubility of Ibu reduces remarkably by a 
reduction in pH, therefore, this could be the reason for poor solubility of coground samples 
containing high concentration of GL.  
 
Effect of grinding on the morphology of Ibu-GL formulations 
SEM images of untreated Ibu, untreated GL and some of formulations mixtures of Ibu-GL 
are shown in Figure 6. The figure shows that untreated ibuprofen is elongated in shape 
whereas GL particles are prismatic crystals. The SEM images of ground GL showed that 
under grinding larger particles were broken down into smaller particles as the grinding time 
increased (Figure 6). This was supported by the particle size analysis listed in Table 2. The 
table shows that when the grinding time increased from 0 to 20 min the mean particle size 
(D50%) was reduced from 259.3±0.4 to 12.8±0.5 µm (around 20 times reduction in particle 
size). Whereas in case of pure ibuprofen the mean particle size was reduced 3 times as the 
grinding time was increased from 0 (29.1±0.6 µm) to 20 min (9.8±0.3 µm) (Table 2). 
Comparing SEM images of coground samples for ratio of Ibu:GL 4:1 ground for 1 min 
(Figure 6) and 20 min (Figure 6) showed that there was still a  number of original ibuprofen 
crystals present after 1 min grinding. In the case of the high concentration of GL (Ibu:GL 
1:10) smaller average particles (Figure 6 and Table 2) were  obtained for 20 min grinding 
time (1.9±0.04 µm) compared to 1 min grinding (20.0±1.1 µm). This could be attributed to 
the fragile nature of GL crystals as discussed for grinding of pure GL. 
 
SEM images of the physical mixtures of ground ibuprofen with unground GL shows that the 
ground ibuprofen particles adhered to the surface of large unground GL particles (Figure 6) 
when the concentration of GL is very high. This is less obvious for the samples containing 
80% Ibu and 20% GL (Ibu:GL 4:1). The dispersion of ground ibuprofen on large unground 
GL particles could be a reason for better dissolution of these samples. 
 
 Solid state characterization     
FT-IR analysis was carried out on all samples to confirm any structural changes at the 
molecular level. FT-IR spectra for ibuprofen samples ground for different grinding times are 
shown in Figure 7(I). Bands characteristic of ibuprofen were found at 1710 cm-1 and 2955 
cm-1, due to carbonyl and hydroxyl stretching vibration respectively. It is apparent from the 
FT-IR spectra that the samples of ibuprofen subjected to different grinding times exhibited 
similar IR spectra as the same peaks at the same wavenumber are seen for ground ibuprofen. 
This indicates that ibuprofen is stable under grinding conditions on its own and no structural 
changes at the molecular level were associated with it.  
 
In order to investigate the effect of grinding on Ibu in the presence of GL, the lowest and 
highest grinding times for different ratios of Ibu:GL (4:1, 1:4 and 1:10) were selected and 
their FT-IR spectra are shown in Figure 7(II). All coground samples showed the same 
characteristic band for the presence of GL (3288 cm-1) in the samples. Whereas the 
characteristic band at 1710 cm-1 was shifted to higher wavenumbers when the ratio of Ibu:GL 
decreased. For example at ratio of 4:1 (Ibu:GL) the wavenumber was 1710 cm-1 (similar to 
unground Ibu) whereas at ratios of 1:4 and 1:10 this wavenumber was shifted to 1714 and 
1717 cm-1 respectively when the samples were ground for 20 min. The FT-IR shows that 
grinding time increased the extent of the shift. For example the wavenumber for Ibu:GL 1:10 
ratio ground for 1 and 20 min was 1713 and 1717 cm-1 respectively. In case of physical 
mixtures of Ibu:GL for ratios 4:1 and 1:4 the same wavenumber (1710 cm-1) was observed 
but when the concentration of GL increased (Ibu:GL 1:10) the band was slightly shifted 
towards higher wavenumber (1712 cm-1, FT-IR spectrum was not shown). This indicates that 
grinding is the main factor to cause this shift which could be attributed to the formation of 
intermolecular hydrogen bond or esterification between the carboxylic acid group in the 
ibuprofen and hydroxyl group in the GL. 
 
DSC was used to investigate any changes in the thermal behaviour of ibuprofen or 
glucosamine samples subjected to grinding. The DSC traces of untreated ibuprofen and 
ibuprofen ground for different times are shown in Figure 8. The results showed that the 
untreated ibuprofen had a sharp endothermic peak around 79 °C with an enthalpy of fusion 
around 128 J/g (Table 4). Table 4 shows that as the grinding time increased for the untreated 
ibuprofen, the enthalpy slightly decreased. This could be attributed to the amorphization of 
ibuprofen as a result of grinding. Comparing the enthalpies between grinding time 0 (127.8 
J/g) and 20 min (124.7 J/g) shows that the amorphization did not occur to a large extent. This 
indicates that ibuprofen is stable under grinding conditions of up to 20 min. Similar results 
were reported for glipizide29 where 3 h grinding did not produce a significant amount of 
amorphous content in the samples, whereas in case of clarithromycine, grinding for 30 min 
produced a high content of amorphous region.30  
As all DSC traces for all formulations showed only one peak around the melting point of 
ibuprofen, therefore, we did not include their DSC traces but their melting points and 
enthalpies were listed in Table 4.  It is obvious from Table 4 that there is no significant shift 
in the melting peak of ibuprofen when the ratio of Ibu:GL in the simple physical mixtures 
was reduced from 4:1 (78.9±0.9 0C) to 1:10 (77.6±0.2 0C). The intensity of peak reduces due 
to a reduction in the concentration of drug in the samples as the ratio of drug:carrier reduces. 
This indicates ibuprofen did not interact with glucosamine in the physical mixtures. 
 
The coground samples with the ratio of Ibu:GL 4:1 ground for 1, 10 and 20 min showed 
similar enthalpy and almost similar melting point. When the ratio of ibuprofen:glucosamine 
reduced to 1:4 or 1:10 the same pattern was obtained regarding the melting point of 
ibuprofen, but there were  changes in the enthalpy of the samples which could be due to lack 
of high homogeneity of the samples when the concentration of drug is very low.  
 
Thermal behaviour of coground ibuprofen-GL was compared to the thermal behaviour of 
ground ibuprofen mixed with unground GL. The results did not show big differences in the 
melting peak of ibuprofen between coground formulations and ground ibuprofen-unground 
glucosamine. All these indicated that ibuprofen can be ground and physically mixed with 
glucosamine without any significant interaction between them. Generally coground 
formulations showed slightly higher enthalpies compared to the physical mixtures of ground 
Ibu with unground GL. The difference and variations could be due to the lack of a high 
homogeneity between the samples but it seems coground samples showed better uniformity 
as the difference between the enthalpies for the same ratio for Ibu:GL with the different 
grinding times is less.    
 
Conclusion 
 
The present study showed that the role of glucosamine HCl in coground formulations 
containing ibuprofen is complex. This amino sugar has the capability to enhance the 
solubility and hence the dissolution of ibuprofen. The results showed that ibuprofen is stable 
under grinding condition and can be mixed with glucosamine to improve the dissolution. 
Care must be taken when ibuprofen is ground in the presence of glucosamine as high 
concentration of glucosamine at high grinding time caused slight changes in FT-IR of 
ibuprofen. No changes were reported for coground formulations contacting low concentration 
of glucosamine subjected to low grinding time. The results showed that glucosamine can be 
used as a potential excipient in coground of ibuprofen to enhance the dissolution. 
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Table 1. Effect of cogrinding time on dissolution parameters of physical mixtures 
Drug: carrier 
ratio 
Cogrinding timea  DE120min 
(%) 
MDT  
(min) 
MDR 
(%.min-1) 
Ibuprofen 0 45.4 ± 5.7 45.8 ± 1.4 0.79 ± 0.10 
Ibuprofen 1 32.6 ± 2.9   46.7 ± 8.9  0.55 ± 0.07 
Ibuprofen 10 38.9 ± 4.7 48.9 ± 6.7 0.67 ± 0.05 
Ibuprofen 20 39.2 ± 11.8 53.3 ± 10.1 0.71 ± 0.10 
4:1 0 31.5 ± 7.8 45.5 ± 5.7 0.50 ± 0.14 
4:1 1 69.0 ± 0.1 27.7 ± 3.2 1.14 ± 0.02 
4:1 10 64.5 ± 7.1 33.5 ± 3.2 1.09 ± 0.14 
4:1 20 64.8 ± 12.3 39.7 ± 10.2 1.10 ± 0.20 
1:4 0 37.3 ± 8.4 52.1 ± 2.4 0.65 ± 0.16 
1:4 1 45.8 ± 7.3 30.3 ± 1.9 0.90 ± 0.14 
1:4 10 37.7 ± 5.8 51.6 ± 6.7 0.66 ± 0.08 
1:4 20 43.8 ± 5.9 49.3 ± 2.8 0.70 ± 0.08 
1:10 0 49.6 ± 1.0 40.9 ± 5.1 0.87 ± 0.04 
1:10 1 27.9 ± 5.2 31.1 ± 2.1 0.53 ± 0.11 
1:10 10 37.6 ± 4.1 54.4 ± 3.0 0.62 ± 0.03 
1:10 20 32.6 ± 4.0 46.1 ± 6.7 0.56 ± 0.06 
Mixtures of ground Ibu-Unground GL    
4:1 1 44.9 ± 4.5 49.4 ± 2.6 0.76 ± 0.07 
4:1 10 59.5 ± 6.4 33.7 ± 2.7 1.00 ± 0.10 
4:1 20 59.7 ± 4.2 26.8 ± 4.6 0.98 ± 0.08 
1:4 1 54.0 ± 10.5 34.3 ± 6.7 0.90 ± 0.20 
1:4 10 44.2 ± 7.9 18.3 ± 4.5 0.92 ± 0.20 
1:4 20 52.7 ± 3.9 35.5 ± 1.7 0.90 ± 0.08 
1:10 1 45.8 ± 5.7 32.0 ± 6.5 0.80 ± 0.12 
1:10 10 69.2 ± 6.6 13.8 ± 6.6 1.50 ± 0.12 
1:10 20 68.0 ± 0.5 13.1 ± 4.2 1.40 ± 0.04 
  
   
aCogrinding time 0 min is the physical mixture for 10 min simple mixing 
 
Table 2. Particle size analysis of formulation samples subjected to various processes 
 
Formula 
Grinding 
Time 
(min) 
D10% 
(µm) 
D50% 
(µm) 
D90% 
(µm) 
Span 
IBU 0 5.9 ± 0.3 29.1 ± 0.6 83.9 ± 1.5 2.68 
IBU 1 2.5 ± 0.1 16.0 ± 0.2 87.6 ± 3.5 5.31 
IBU 10 1.2 ± 0.1 9.1 ± 0.7 128.3 ± 1.3 14.00 
IBU 20 1.3 ± 0.1 9.8 ± 0.3 125.5 ± 2.0 12.60 
Glucosamine  0 96.4 ± 3.3 259.3 ± 0.4 328.5 ± 0.2 0.89 
Glucosamine 1 1.5 ± 0.1 22.7 ± 0.2 126.2 ± 0.2 5.50 
Glucosamine 10 0.8 ± 0.1 5.2 ± 0.8 120.6 ± 8.9 23.00 
Glucosamine 20 1.5 ± 0.1 12.8 ± 0.5 140.7 ± 0.7 10.80 
PM of Ibu:GL 
(4:1)  5.5 ± 1.1 30 ± 1.8 103.6 ± 2.6 3.27 
(1:4)  5.7 ± 0.5 47.6 ± 1.9 145.2 ± 0.3 2.93 
(1:10)  8.4 ± 0.7 88.9 ± 2.6 152.3 ± 0.7 1.62 
Coground Ibu:GL 
(4:1) 1 2.6 ± 0.2 19.7 ± 0.8 117.6 ± 0.6 5.83 
(1:4) 1 1.7 ± 0.1 18.6 ± 0.1 116.6 ± 0.1 6.17 
(1:10) 1 1.5 ± 0.1 20.0 ±1.1 127.1 ± 1.0 6.28 
(4:1) 10 1.3 ± 0.1 11.3 ± 0.1 120.4 ± 0.1 10.60 
(1:4) 10 0.7 ± 0.1 2.4 ± 0.02 12.4 ± 0.0 4.83 
(1:10) 10 0.7 ± 0.1 2.07 ± 0.2 13.2 ± 1.4 6.04 
(4:1) 20 1.2 ± 0.2 13.7 ± 0.2 122.3 ± 0.8 8.83 
(1:4) 20 0.7 ± 0.1 3.6 ± 0.2 116.5 ± 3.5 32.30 
(1:10) 20 0.7 ± 0.0 1.9 ± 0.1 12.5 ± 0.5 6.13 
Ground Ibu:Unground GL 
(4:1) 1 2.0 ± 0.2 16.7 ± 0.7 121.9 ± 0.6 
 7.17 
(1:4) 1 4.3 ± 0.5 80.9 ± 0.4 151.6 ± 1.2 
 1.82 
(1:10) 1 3.6 ± 0.3  81.9 ± 9.0 151.7 ± 0.9 
 1.82 
(4:1) 10 1.7 ± 0.4 14.6 ± 0.2  140.7 ± 1.3  9.53 
(1:4) 10 4.1 ± 0.2 101 ± 0.3 154.7 ± 1.2   1.49 
(1:10) 10 2.7 ± 0.2 85.1 ± 5.2 152.1 ± 0.6  1.76 
(4:1) 20 1.2 ± 0.1 10.9 ± 1.3 138.2 ± 1.2 12.50 
(1:4) 20 1.5 ± 0.1 28.1 ± 8.5 144.5 ± 1.6   5.09 
(1:10) 20 2.3 ± 0.1 87.6 ± 2.1 152.8 ± 0.4   1.72 
aThese formulations are subjected to 10 min simple physical mixture in turbula blender  
 
 
 
Table 3. Solubility of ibuprofen in presence of different concentrations of glucosamine after 
72 h 
Formulation 
pH 
nominal/final mg/ml   
Untreated Ibuprofen 7.4/6.4 6.6 ± 0.8 
Untreated Ibuprofen in presence of: 
1% carrier 
 
7.4/6.1 
 
   10.5 ± 2.8 
5% carrier 7.4/4.2 21.2 ± 1.0 
10% carrier 7.4/2.7 15.5 ± 1.1 
15% carrier 7.4/2.2 12.3 ± 0.5 
Table 4. Enthalpy and fusion or transition temperature of various Ibuprofen samples 
containing glucosamine 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Formula Grinding Time (min) Melting peak (oC) Enthalpy (J/g) 
Untreated Ibuprofen --- 78.6 ± 0.1 127.8 ± 4.4 
Untreated Ibuprofen 1 77.9 ± 0.2 127.2 ± 2.1 
Untreated Ibuprofen 10 77.4 ± 0.2 126.9 ± 5.9 
Untreated Ibuprofen 20 76.6 ± 0.4 124.7 ± 4.1 
Physical mixtures Ibu:GL    
(4:1) 0 78.9 ± 0.9 99.1 ± 2.2 
(1:4) 0 77.5 ± 0.2 22.3 ± 1.4 
(1:10) 0 77.1 ± 0.02 8.2 ± 1.9 
Coground Ibu:GL    
(4:1) 1 77.3 ± 0.3 98.1 ± 6.0 
(4:1) 10 76.8 ± 0.2 99.9 ± 0.8 
(4:1) 20 76.6 ± 0.1 99.0 ± 3.5 
(1:4) 1 77.1 ± 0.1 26.2 ± 1.4 
(1:4) 10 76.4 ± 0.1 28.1 ± 2.8 
(1:4) 20 76.2 ± 0.1 25.6 ± 1.4 
(1:10) 1 76.9 ± 0.1 10.4 ± 0.1 
(1:10) 10 76.1 ± 0.1 11.3 ± 1.5 
(1:10) 20 76.3 ± 0.1 11.6 ± 0.4 
Ground Ibu:Unground GL    
(4:1) 1 77.6 ± 0.3 100.5 ± 8.6  
(4:1) 10 77.8 ± 1.1 100.4 ± 4.0 
(4:1) 20 76.8 ± 0.3 94.5 ± 6.9 
(1:4) 1 77.3 ± 0.1 17.9 ± 4.2  
(1:4) 10 76.5 ± 0.2 14.1 ± 2.1 
(1:4) 20 76.5 ± 0.3 21.8 ± 0.6 
(1:10) 1 76.5 ± 0.1 9.3 ± 1.0 
(1:10) 10 77.1 ± 1.2 9.8 ± 0.4 
(1:10) 20 76.3 ± 0.3 10.4 ± 0.4 
 Figure 1. The effect of grinding time on dissolution rate of ibuprofen from coground 
formulations with different ratios of Ibuprofen:glucosamine (drug:carrier): (a) 4:1; (b) 1:4; (c) 
1:10 (COG=coground).  
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 Figure 2. Dissolution profiles of Ibuprofen from physical mixtures with different ratios of 
drug-glucosamine. 
 
Figure 3. The dissolution behaviour of pure Ibuprofen subjected to different grinding times 
(G=grinding).  
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 Figure 4. Dissolution profiles of untreated Ibuprofen with different particle size (data are 
mean and standard deviations of minimum 3 determinations). 
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Figure 5. Dissolution behaviour of Ibuprofen-glucosamine mixture where ibuprofen 
subjected to different milling times followed by mixing with glucosamine for 10 min with 
different ratios of ibuprofen:glucosamine (drug:carrier): (a) 4:1; (b) 1:4; (c) 1:10 (G=ground; 
UG=unground). 
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Coground Ibu:GL (1:10) 1 min 
G 
Coground Ibu:GL (4:1) 1 min G 
(a) Untreated Ibuprofen (b) Glucosamine HCl 
Coground Ibu:GL (4:1) 20 min 
G 
Coground  Ibu:GL (1:10) 20 
min G 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. SEM images of ibuprofen, glucosamine and various coground formulations 
(Ibu=ibuprofen; GL=glucosamine;  G=grinding; UG=unground) 
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Figure 7. FT-IR spectra of ibuprofen ground for (I) 1, 10 and 20 min;  and II: (a) 
glucosamine, (b) ibuprofen;  and coground Ibu-GL ground for 1 min: (c) 4:1, (d) 1:4 and (e) 
1:10 ; and ground for 20 min: (f) 4:1, (g) 1:4 and (h) 1:10.  
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 Figure 8. DSC traces of (a) original ibuprofen, ground Ibuprofen (b) 1 min, (c) 10 min, (d) 20 
min scanned at 10 oC/min. 
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